LRRK2 - Wikipedia
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. - Abstract - Europe PMC
LRRK2 Gene - GeneCards | LRRK2 Protein | LRRK2 Antibody
LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. - Abstract - Europe PMC
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. - Abstract - Europe PMC
LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway. - Abstract - Europe PMC
LRRK2 Gene - GeneCards | LRRK2 Protein | LRRK2 Antibody
anti-LRRK2 antibody (N-Term) | Product No. ABIN7044716
Cdk5 and GSK3β inhibit fast endophilin-mediated endocytosis | Nature Communications
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway | Molecular Neurodegeneration | Full Text
Cdk5 and GSK3β inhibit Fast Endophilin-Mediated Endocytosis | bioRxiv
Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson's Disease-Linked LRRK2 Mutant G2019S | Biochemistry
Regulators of proteostasis are translationally repressed in fibroblasts from sporadic and LRRK2-G2019S Parkinson's patients | bioRxiv
Biomolecules | Free Full-Text | Kinases on Double Duty: A Review of UniProtKB Annotated Bifunctionality within the Kinome | HTML
Cdk5 and GSK3β inhibit fast endophilin-mediated endocytosis
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease - Abdelmoaty - 2022 - Clinical and Translational Medicine - Wiley Online Library
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. - Abstract - Europe PMC
Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides | ACS Chemical Biology
Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1
Cocrystal structure of Roco4 kinase and LRRK2-IN-1. (A) Overlay of the... | Download Scientific Diagram
PDF) Mitochondrial membrane proteins and VPS35 orchestrate selective removal of mtDNA.
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway | Molecular Neurodegeneration | Full Text
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models. - Abstract - Europe PMC
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. - Abstract - Europe PMC
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway | Molecular Neurodegeneration | Full Text
